Cargando…

Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents

Eighteen previously undescribed trimethoprim (TMP) analogs containing amide bonds (1–18) were synthesized and compared with TMP, methotrexate (MTX), and netropsin (NT). These compounds were designed as potential minor groove binding agents (MGBAs) and inhibitors of human dihydrofolate reductase (hDH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wróbel, Agnieszka, Baradyn, Maciej, Ratkiewicz, Artur, Drozdowska, Danuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037161/
https://www.ncbi.nlm.nih.gov/pubmed/33916202
http://dx.doi.org/10.3390/ijms22073685
_version_ 1783677078907912192
author Wróbel, Agnieszka
Baradyn, Maciej
Ratkiewicz, Artur
Drozdowska, Danuta
author_facet Wróbel, Agnieszka
Baradyn, Maciej
Ratkiewicz, Artur
Drozdowska, Danuta
author_sort Wróbel, Agnieszka
collection PubMed
description Eighteen previously undescribed trimethoprim (TMP) analogs containing amide bonds (1–18) were synthesized and compared with TMP, methotrexate (MTX), and netropsin (NT). These compounds were designed as potential minor groove binding agents (MGBAs) and inhibitors of human dihydrofolate reductase (hDHFR). The all-new derivatives were obtained via solid phase synthesis using 4-nitrophenyl Wang resin. Data from the ethidium displacement test confirmed their DNA-binding capacity. Compounds 13–14 (49.89% and 43.85%) and 17–18 (41.68% and 42.99%) showed a higher binding affinity to pBR322 plasmid than NT. The possibility of binding in a minor groove as well as determination of association constants were performed using calf thymus DNA, T4 coliphage DNA, poly (dA-dT)(2), and poly (dG-dC)(2). With the exception of compounds 9 (IC50 = 56.05 µM) and 11 (IC50 = 55.32 µM), all of the compounds showed better inhibitory properties against hDHFR than standard, which confirms that the addition of the amide bond into the TMP structures increases affinity towards hDHFR. Derivatives 2, 6, 13, 14, and 16 were found to be the most potent hDHFR inhibitors. This molecular modelling study shows that they interact strongly with a catalytically important residue Glu-30.
format Online
Article
Text
id pubmed-8037161
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80371612021-04-12 Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents Wróbel, Agnieszka Baradyn, Maciej Ratkiewicz, Artur Drozdowska, Danuta Int J Mol Sci Article Eighteen previously undescribed trimethoprim (TMP) analogs containing amide bonds (1–18) were synthesized and compared with TMP, methotrexate (MTX), and netropsin (NT). These compounds were designed as potential minor groove binding agents (MGBAs) and inhibitors of human dihydrofolate reductase (hDHFR). The all-new derivatives were obtained via solid phase synthesis using 4-nitrophenyl Wang resin. Data from the ethidium displacement test confirmed their DNA-binding capacity. Compounds 13–14 (49.89% and 43.85%) and 17–18 (41.68% and 42.99%) showed a higher binding affinity to pBR322 plasmid than NT. The possibility of binding in a minor groove as well as determination of association constants were performed using calf thymus DNA, T4 coliphage DNA, poly (dA-dT)(2), and poly (dG-dC)(2). With the exception of compounds 9 (IC50 = 56.05 µM) and 11 (IC50 = 55.32 µM), all of the compounds showed better inhibitory properties against hDHFR than standard, which confirms that the addition of the amide bond into the TMP structures increases affinity towards hDHFR. Derivatives 2, 6, 13, 14, and 16 were found to be the most potent hDHFR inhibitors. This molecular modelling study shows that they interact strongly with a catalytically important residue Glu-30. MDPI 2021-04-01 /pmc/articles/PMC8037161/ /pubmed/33916202 http://dx.doi.org/10.3390/ijms22073685 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wróbel, Agnieszka
Baradyn, Maciej
Ratkiewicz, Artur
Drozdowska, Danuta
Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents
title Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents
title_full Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents
title_fullStr Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents
title_full_unstemmed Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents
title_short Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents
title_sort synthesis, biological activity, and molecular dynamics study of novel series of a trimethoprim analogs as multi-targeted compounds: dihydrofolate reductase (dhfr) inhibitors and dna-binding agents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037161/
https://www.ncbi.nlm.nih.gov/pubmed/33916202
http://dx.doi.org/10.3390/ijms22073685
work_keys_str_mv AT wrobelagnieszka synthesisbiologicalactivityandmoleculardynamicsstudyofnovelseriesofatrimethoprimanalogsasmultitargetedcompoundsdihydrofolatereductasedhfrinhibitorsanddnabindingagents
AT baradynmaciej synthesisbiologicalactivityandmoleculardynamicsstudyofnovelseriesofatrimethoprimanalogsasmultitargetedcompoundsdihydrofolatereductasedhfrinhibitorsanddnabindingagents
AT ratkiewiczartur synthesisbiologicalactivityandmoleculardynamicsstudyofnovelseriesofatrimethoprimanalogsasmultitargetedcompoundsdihydrofolatereductasedhfrinhibitorsanddnabindingagents
AT drozdowskadanuta synthesisbiologicalactivityandmoleculardynamicsstudyofnovelseriesofatrimethoprimanalogsasmultitargetedcompoundsdihydrofolatereductasedhfrinhibitorsanddnabindingagents